Kerala Ayurveda
- Market cap
- ₹ 169 Cr.
- P/E
- 346x
- P/B
- 15.94x
- 52-week range
- 130 – 448
- ROE
- −161%
- ROCE
- −10%
- Dividend yield
- 0%
- Debt / equity
- 7.77
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
About
Kerala Ayurveda Limited is an India-based company. The Company is primarily focused in the area of manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs and maintaining herbarium of medicinal plants. The Company's product categories include diabetic care, heart health, lung health, gut health, joint relief, pain relief, skin care, hair care, immunity, stress management, cognitive function, weight management, cough & cold relief, allergy care, eye care, kidney health, men's health, women's health, kid's health, liver health, strength and stamina, hair oils, face oils, massage oils, ayurvedic capsules, ayurvedic tablets, choornams, lehyams, ayurvedic ghee, and more. The Company's subsidiaries include Ayurvedagram Heritage Wellness Centre Pvt Ltd., Ayurvedic Academy Inc, Suveda Inc, Ayu Natural Medicine Clinic PS, CM S Katra Holdings LLC, and Nutraveda Pte Ltd.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Kerala Ayurveda against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)346 against a typical 33.2: pricier than most peers (1st = cheapest).212th of 220
- Sales growth+16% against a typical +15.6% from a year earlier.97th of 197
- Profit growth−498% against a typical +18.9% from a year earlier.158th of 160
- Share price, 3 months−5.5% against a typical −2%.124th of 200
- Size₹ 169.1 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).125th of 199
Research by Minerva Capital Research Solutions
Our research team's work on Kerala AyurvedaAlso covered in
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25 | 26 | 32 | 27 | 30 | 31 | 31 | 29 | 35 | 33 | 35 | 33 |
| Expenses | 24 | 25 | 27 | 27 | 25 | 32 | 41 | 33 | 40 | 34 | 42 | 37 |
| Operating Profit | 1 | 1 | 5 | 1 | 6 | −1 | −10 | −4 | −5 | −2 | −7 | −4 |
| OPM % | 2.2% | 3.8% | 17% | 2.9% | 18.2% | −3.8% | −32.4% | −14.7% | −14.2% | −4.6% | −20.4% | −11.5% |
| Other Income | 1 | 0 | −1 | 0 | 1 | 0 | 1 | 9 | 2 | 1 | 2 | 0 |
| Interest | 1 | 1 | 3 | 0 | 1 | 0 | 2 | 1 | 3 | 3 | 1 | 3 |
| Depreciation | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 |
| Profit before tax | 0 | 0 | 0 | 0 | 3 | −2 | −14 | 3 | −7 | −4 | −8 | −8 |
| Tax % | 100% | 369% | −194.4% | −125% | −4.9% | 28% | 11.3% | 27.8% | −6.7% | 5.3% | −7.4% | −1.8% |
| Net Profit | 0 | −1 | 1 | 0 | 4 | −3 | −15 | 2 | −6 | −5 | −7 | −8 |
| EPS in Rs | −0.12 | −0.9 | 0.22 | 0.27 | 2.84 | −2.4 | −12.92 | 1.65 | −5.26 | −3.69 | −5.97 | −6.14 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 11%
- 5 Years
- 16%
- 3 Years
- 12%
- TTM
- 12%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −104%
- 10 Years
- 11%
- 5 Years
- 26%
- 3 Years
- 19%
- TTM
- —
- 10 Years
- −36%
- 5 Years
- −69%
- 3 Years
- −85%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Kerala Ayurveda | ₹ 144.75 | ₹ 169 Cr. | 346x | 15.9x | −161% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Vivek Sunder
- Chief Executive Officer
- George K T
- Chief Financial Officer
- Binu Thomas
- Compliance Officer, Company Secretary
- Kunjupanicker G. Anilkumar
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.